These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30696606)

  • 1. Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer's disease?
    Gofrit ON; Bercovier H; Klein BY; Cohen IR; Ben-Hur T; Greenblatt CL
    Med Hypotheses; 2019 Feb; 123():95-97. PubMed ID: 30696606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    Gofrit ON; Klein BY; Cohen IR; Ben-Hur T; Greenblatt CL; Bercovier H
    PLoS One; 2019; 14(11):e0224433. PubMed ID: 31697701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain.
    Zuo Z; Qi F; Yang J; Wang X; Wu Y; Wen Y; Yuan Q; Zou J; Guo K; Yao ZB
    Neurobiol Dis; 2017 May; 101():27-39. PubMed ID: 28189498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin strain differences as the basis for immunotherapies against bladder cancer.
    Miyazaki J; Onozawa M; Takaoka E; Yano I
    Int J Urol; 2018 May; 25(5):405-413. PubMed ID: 29506322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer.
    Kim JI; Zhu D; Barry E; Kovac E; Aboumohamed A; Agalliu I; Sankin A
    Clin Genitourin Cancer; 2021 Dec; 19(6):e409-e416. PubMed ID: 34116955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
    Kudo T; Iwasa N; Maeda S; Mitarai S
    Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
    Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
    Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary disease following intravesical BCG treatment.
    Kesten S; Title L; Mullen B; Grossman R
    Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.
    Luo Y; Chen X; Downs TM; DeWolf WC; O'Donnell MA
    J Immunol; 1999 Feb; 162(4):2399-405. PubMed ID: 9973521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
    Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease.
    Klinger D; Hill BL; Barda N; Halperin E; Gofrit ON; Greenblatt CL; Rappoport N; Linial M; Bercovier H
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34064775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guérin.
    Liu X; Dowell AC; Patel P; Viney RP; Foster MC; Porfiri E; James ND; Bryan RT
    Future Oncol; 2014 Jun; 10(8):1443-56. PubMed ID: 25052754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
    Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
    Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.
    Guerra CE; Betts RF; O'Keefe RJ; Shilling JW
    Clin Infect Dis; 1998 Sep; 27(3):639-40. PubMed ID: 9770167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non muscle invasive bladder tumor related to the problem of bacillus Calmette-Guerin availability. Consensus of a Spanish expert's panel. Spanish Association of Urology.
    Fernández-Gómez JM; Carballido-Rodríguez J; Cozar-Olmo JM; Palou-Redorta J; Solsona-Narbón E; Unda-Urzaiz JM;
    Actas Urol Esp; 2013; 37(7):387-94. PubMed ID: 23773824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer.
    Herr HW; Dalbagni G
    BJU Int; 2013 May; 111(6):984-7. PubMed ID: 23351086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.